AI assistant
Pennant Group, Inc. — Director's Dealing 2019
Oct 3, 2019
32342_dirs_2019-10-03_708ae2dd-c2f0-49f9-ae5d-71dc14da1d0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pennant Group, Inc. (PNTG)
CIK: 0001766400
Period of Report: 2019-10-01
Reporting Person: Freeman Jennifer (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-01 | Common Stock | A | 7141 | $0.00 | Acquired | 7141 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-01 | Stock Option (right to buy) | $15.09 | A | 12000 | Acquired | 2029-10-01 | Common Stock (12000) | Direct |
Footnotes
F1: Shares of Cornerstone Healthcare, Inc. converted into shares of The Pennant Group, Inc. (the "Registrant") pursuant to the merger of Cornerstone Merger Sub, Inc., a wholly-owned subsidiary of the Registrant, with and into Cornerstone Healthcare, Inc., with Cornerstone Healthcare, Inc. as the surviving corporation, in connection with the spin-off of the Registrant from The Ensign Group, Inc
F2: Options granted on October 1, 2019 under The Pennant Group, Inc. 2019 Omnibus Incentive Plan. The options vest in five equal annual installments beginning on the first anniversary of the date of the grant.